Publicacións nas que colabora con Moisés Rodríguez Mañero (107)

2024

  1. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

    Journal of Cardiovascular Translational Research, Vol. 17, Núm. 1, pp. 13-23

  2. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation

  3. Impact of a clinician-to-clinician electronic consultation in heart failure patients with previous hospital admissions

    European Heart Journal - Digital Health, Vol. 5, Núm. 1, pp. 9-20

  4. Impact of initiation of SGLT2 inhibitor treatment on the development of arrhythmias in patients with implantable cardiac devices

    Revista Espanola de Cardiologia

  5. Pseudotransposition of the great leads

    PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 2, pp. 233-235

2023

  1. Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066

  2. Characterization of Atrial Substrate to Predict the Success of Pulmonary Vein Isolation: The Prospective, Multicenter MASH-AF II (Multipolar Atrial Substrate High Density Mapping in Atrial Fibrillation) Study

    Journal of the American Heart Association, Vol. 12, Núm. 1, pp. e027795

  3. Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

    Cells, Vol. 12, Núm. 4

  4. Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials

    The American journal of cardiology, Vol. 205, pp. 321-324

  5. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  6. Clinical and cost-effectiveness results of an on-call program for pacemaker implantations

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 936-937

  7. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  8. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

    Thrombosis Research, Vol. 224, pp. 46-51

  9. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  10. Effects of guideline-directed medical therapy in patients with left bundle branch block-induced cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 238-244

  11. Endocardial ganglionated plexi ablation in a patient with cardioinhibitory carotid sinus syndrome

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 66-67

  12. Gender differences on healthcare accessibility and outcomes of a electronic inter-clinician consultation program at the cardiology department in a Galician Health Area

    European Journal of Clinical Investigation, Vol. 53, Núm. 9

  13. Gender-Related Differences in Atrial Substrate in Patients with Atrial Fibrillation

    American Journal of Cardiology, Vol. 203, pp. 451-458

  14. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

  15. Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas

    International Journal of Molecular Sciences, Vol. 24, Núm. 20